Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 94 pages | ID: GFE5B16B16CAEN
QYResearch

Abstracts

This report focuses on the global Type-1 Diabetes Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Type-1 Diabetes Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astellas Pharma
• Merck
• Eli Lilly
• Novo Nordisk
• Sanofi
• AstraZeneca
• Boehringer Ingelheim GmbH
• Novartis
• Pfizer Inc.
• Abbott Laboratories
• Mannkind Corporation
• Braun Melsungen AG
• Macrogenics, Inc.

Market segment by Type, the product can be split into

• Rapid-Acting Insulin
• Short-Acting Insulin
• Others

Market segment by Application, split into

• Hospitals & Clinics
• Academic & Research Institutes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Type-1 Diabetes Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Type-1 Diabetes Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Type-1 Diabetes Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rapid-Acting Insulin
  1.4.3 Short-Acting Insulin
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Type-1 Diabetes Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinics
  1.5.3 Academic & Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Type-1 Diabetes Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Type-1 Diabetes Treatment Industry
    1.6.1.1 Type-1 Diabetes Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Type-1 Diabetes Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Type-1 Diabetes Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Type-1 Diabetes Treatment Market Perspective (2015-2026)
2.2 Type-1 Diabetes Treatment Growth Trends by Regions
  2.2.1 Type-1 Diabetes Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Type-1 Diabetes Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Type-1 Diabetes Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Type-1 Diabetes Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Type-1 Diabetes Treatment Players by Market Size
  3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2015-2020)
  3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Type-1 Diabetes Treatment Market Concentration Ratio
  3.2.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2019
3.3 Type-1 Diabetes Treatment Key Players Head office and Area Served
3.4 Key Players Type-1 Diabetes Treatment Product Solution and Service
3.5 Date of Enter into Type-1 Diabetes Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2015-2020)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2021-2026)

5 TYPE-1 DIABETES TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Type-1 Diabetes Treatment Market Size by Application (2015-2020)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Type-1 Diabetes Treatment Market Size (2015-2020)
6.2 Type-1 Diabetes Treatment Key Players in North America (2019-2020)
6.3 North America Type-1 Diabetes Treatment Market Size by Type (2015-2020)
6.4 North America Type-1 Diabetes Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Type-1 Diabetes Treatment Market Size (2015-2020)
7.2 Type-1 Diabetes Treatment Key Players in Europe (2019-2020)
7.3 Europe Type-1 Diabetes Treatment Market Size by Type (2015-2020)
7.4 Europe Type-1 Diabetes Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Type-1 Diabetes Treatment Market Size (2015-2020)
8.2 Type-1 Diabetes Treatment Key Players in China (2019-2020)
8.3 China Type-1 Diabetes Treatment Market Size by Type (2015-2020)
8.4 China Type-1 Diabetes Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Type-1 Diabetes Treatment Market Size (2015-2020)
9.2 Type-1 Diabetes Treatment Key Players in Japan (2019-2020)
9.3 Japan Type-1 Diabetes Treatment Market Size by Type (2015-2020)
9.4 Japan Type-1 Diabetes Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Type-1 Diabetes Treatment Market Size (2015-2020)
10.2 Type-1 Diabetes Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Type-1 Diabetes Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Type-1 Diabetes Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Type-1 Diabetes Treatment Market Size (2015-2020)
11.2 Type-1 Diabetes Treatment Key Players in India (2019-2020)
11.3 India Type-1 Diabetes Treatment Market Size by Type (2015-2020)
11.4 India Type-1 Diabetes Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Type-1 Diabetes Treatment Market Size (2015-2020)
12.2 Type-1 Diabetes Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Type-1 Diabetes Treatment Market Size by Type (2015-2020)
12.4 Central & South America Type-1 Diabetes Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas Pharma
  13.1.1 Astellas Pharma Company Details
  13.1.2 Astellas Pharma Business Overview and Its Total Revenue
  13.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
  13.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2015-2020))
  13.1.5 Astellas Pharma Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Type-1 Diabetes Treatment Introduction
  13.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Details
  13.3.2 Eli Lilly Business Overview and Its Total Revenue
  13.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
  13.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.3.5 Eli Lilly Recent Development
13.4 Novo Nordisk
  13.4.1 Novo Nordisk Company Details
  13.4.2 Novo Nordisk Business Overview and Its Total Revenue
  13.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
  13.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.4.5 Novo Nordisk Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Type-1 Diabetes Treatment Introduction
  13.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.5.5 Sanofi Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
  13.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 Boehringer Ingelheim GmbH
  13.7.1 Boehringer Ingelheim GmbH Company Details
  13.7.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  13.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
  13.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.7.5 Boehringer Ingelheim GmbH Recent Development
13.8 Novartis
  13.8.1 Novartis Company Details
  13.8.2 Novartis Business Overview and Its Total Revenue
  13.8.3 Novartis Type-1 Diabetes Treatment Introduction
  13.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.8.5 Novartis Recent Development
13.9 Pfizer Inc.
  13.9.1 Pfizer Inc. Company Details
  13.9.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
  13.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.9.5 Pfizer Inc. Recent Development
13.10 Abbott Laboratories
  13.10.1 Abbott Laboratories Company Details
  13.10.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
  13.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  13.10.5 Abbott Laboratories Recent Development
13.11 Mannkind Corporation
  10.11.1 Mannkind Corporation Company Details
  10.11.2 Mannkind Corporation Business Overview and Its Total Revenue
  10.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
  10.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  10.11.5 Mannkind Corporation Recent Development
13.12 Braun Melsungen AG
  10.12.1 Braun Melsungen AG Company Details
  10.12.2 Braun Melsungen AG Business Overview and Its Total Revenue
  10.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
  10.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  10.12.5 Braun Melsungen AG Recent Development
13.13 Macrogenics, Inc.
  10.13.1 Macrogenics, Inc. Company Details
  10.13.2 Macrogenics, Inc. Business Overview and Its Total Revenue
  10.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
  10.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020)
  10.13.5 Macrogenics, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Type-1 Diabetes Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
Table 3. Ranking of Global Top Type-1 Diabetes Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rapid-Acting Insulin
Table 6. Key Players of Short-Acting Insulin
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Type-1 Diabetes Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Type-1 Diabetes Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Type-1 Diabetes Treatment Players to Combat Covid-19 Impact
Table 13. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Type-1 Diabetes Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Type-1 Diabetes Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Type-1 Diabetes Treatment Market Share by Regions (2015-2020)
Table 17. Global Type-1 Diabetes Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Type-1 Diabetes Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Type-1 Diabetes Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Type-1 Diabetes Treatment Players
Table 24. Global Type-1 Diabetes Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Type-1 Diabetes Treatment Market Share by Players (2015-2020)
Table 26. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type-1 Diabetes Treatment as of 2019)
Table 27. Global Type-1 Diabetes Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Type-1 Diabetes Treatment Product Solution and Service
Table 30. Date of Enter into Type-1 Diabetes Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Type-1 Diabetes Treatment Market Size Share by Type (2015-2020)
Table 34. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Type-1 Diabetes Treatment Market Size Share by Application (2015-2020)
Table 36. Global Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Type-1 Diabetes Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 40. North America Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 42. North America Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 46. Europe Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 48. Europe Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 52. China Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 54. China Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 58. Japan Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 60. Japan Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 64. Southeast Asia Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 70. India Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 72. India Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Type-1 Diabetes Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Type-1 Diabetes Treatment Market Share (2019-2020)
Table 76. Central & South America Type-1 Diabetes Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Type-1 Diabetes Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Type-1 Diabetes Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Type-1 Diabetes Treatment Market Share by Application (2015-2020)
Table 80. Astellas Pharma Company Details
Table 81. Astellas Pharma Business Overview
Table 82. Astellas Pharma Product
Table 83. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 84. Astellas Pharma Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Product
Table 93. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 94. Eli Lilly Recent Development
Table 95. Novo Nordisk Company Details
Table 96. Novo Nordisk Business Overview
Table 97. Novo Nordisk Product
Table 98. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 99. Novo Nordisk Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Product
Table 103. Sanofi Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 104. Sanofi Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Product
Table 108. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 109. AstraZeneca Recent Development
Table 110. Boehringer Ingelheim GmbH Company Details
Table 111. Boehringer Ingelheim GmbH Business Overview
Table 112. Boehringer Ingelheim GmbH Product
Table 113. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 114. Boehringer Ingelheim GmbH Recent Development
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Company Details
Table 118. Novartis Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 119. Novartis Recent Development
Table 120. Pfizer Inc. Company Details
Table 121. Pfizer Inc. Business Overview
Table 122. Pfizer Inc. Product
Table 123. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 124. Pfizer Inc. Recent Development
Table 125. Abbott Laboratories Company Details
Table 126. Abbott Laboratories Business Overview
Table 127. Abbott Laboratories Product
Table 128. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 129. Abbott Laboratories Recent Development
Table 130. Mannkind Corporation Company Details
Table 131. Mannkind Corporation Business Overview
Table 132. Mannkind Corporation Product
Table 133. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 134. Mannkind Corporation Recent Development
Table 135. Braun Melsungen AG Company Details
Table 136. Braun Melsungen AG Business Overview
Table 137. Braun Melsungen AG Product
Table 138. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 139. Braun Melsungen AG Recent Development
Table 140. Macrogenics, Inc. Company Details
Table 141. Macrogenics, Inc. Business Overview
Table 142. Macrogenics, Inc. Product
Table 143. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2015-2020) (Million US$)
Table 144. Macrogenics, Inc. Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Type-1 Diabetes Treatment Market Share by Type: 2020 VS 2026
Figure 2. Rapid-Acting Insulin Features
Figure 3. Short-Acting Insulin Features
Figure 4. Others Features
Figure 5. Global Type-1 Diabetes Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Academic & Research Institutes Case Studies
Figure 8. Type-1 Diabetes Treatment Report Years Considered
Figure 9. Global Type-1 Diabetes Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Type-1 Diabetes Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Type-1 Diabetes Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Type-1 Diabetes Treatment Market Share by Players in 2019
Figure 14. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type-1 Diabetes Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2019
Figure 16. North America Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Type-1 Diabetes Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 25. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 27. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 29. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 33. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 35. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 37. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 39. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 41. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 43. Mannkind Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 45. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 47. Macrogenics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed